Terms: = Sarcomas AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP
204 results:
1. brd4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines.
Lang C; Stickler S; Rath B; Teufelsbauer M; Weigl L; Hohenegger M; Hamilton G
Anticancer Res; 2024 Mar; 44(3):971-980. PubMed ID: 38423674
[TBL] [Abstract] [Full Text] [Related]
2. Secondary peripheral chondrosarcoma in multiple osteochondromas: a retrospective single-institution case series.
Gnoli M; Gambarotti M; Righi A; Staals EL; Evangelista A; Tremosini M; Brizola E; Mordenti M; Boarini M; Locatelli M; Pedrini E; Sangiorgi L
Orphanet J Rare Dis; 2024 Feb; 19(1):63. PubMed ID: 38351015
[TBL] [Abstract] [Full Text] [Related]
3. Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis.
Humbert P; Kampleitner C; De Lima J; Brennan MÁ; Lodoso-Torrecilla I; Sadowska JM; Blanchard F; Canal C; Ginebra MP; Hoffmann O; Layrolle P
Acta Biomater; 2024 Mar; 176():417-431. PubMed ID: 38272200
[TBL] [Abstract] [Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract] [Full Text] [Related]
5. brd4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma.
Das D; Leung JY; Balamurugan S; Tergaonkar V; Loh AHP; Chiang CM; Taneja R
EMBO Rep; 2024 Feb; 25(2):832-852. PubMed ID: 38191874
[TBL] [Abstract] [Full Text] [Related]
6. Engineering alginate-based injectable hydrogels combined with bioactive polymers for targeted plasma-derived oxidative stress delivery in osteosarcoma therapy.
Espona-Noguera A; Tampieri F; Canal C
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128841. PubMed ID: 38104678
[TBL] [Abstract] [Full Text] [Related]
7. High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient.
Arellano Zameza P; Karklins SP; Pena J; Bowers NL; Samman A; Ahn C; Sangueza OP
Am J Dermatopathol; 2024 Feb; 46(2):101-103. PubMed ID: 38055974
[TBL] [Abstract] [Full Text] [Related]
8. The brd4-SRPK2-SRSF2 signal modulates the splicing efficiency of ACSL3 pre-mRNA and influences erastin-induced ferroptosis in osteosarcoma cells.
Luo SH; Tian JM; Chu Y; Zhu HY; Ni JD; Huang J
Cell Death Dis; 2023 Nov; 14(11):760. PubMed ID: 37993451
[TBL] [Abstract] [Full Text] [Related]
9. KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming.
Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
PLoS Pathog; 2023 Nov; 19(11):e1011771. PubMed ID: 37934757
[TBL] [Abstract] [Full Text] [Related]
10. Biomineralized Polydopamine Nanoparticle-Based Sodium Alginate Hydrogels for Delivery of Anti-serine/Threonine Protein Kinase B-Rapidly Accelerated Fibrosarcoma siRNA for Metastatic Melanoma Therapy.
Lu J; Song J; Zhang P; Huang Y; Lu X; Dai H; Xi J
ACS Nano; 2023 Sep; 17(18):18318-18331. PubMed ID: 37690074
[TBL] [Abstract] [Full Text] [Related]
11. Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Chen AP; Sharon E; O'Sullivan-Coyne G; Moore N; Foster JC; Hu JS; Van Tine BA; Conley AP; Read WL; Riedel RF; Burgess MA; Glod J; Davis EJ; Merriam P; Naqash AR; Fino KK; Miller BL; Wilsker DF; Begum A; Ferry-Galow KV; Deshpande HA; Schwartz GK; Ladle BH; Okuno SH; Beck JC; Chen JL; Takebe N; Fogli LK; Rosenberger CL; Parchment RE; Doroshow JH
N Engl J Med; 2023 Sep; 389(10):911-921. PubMed ID: 37672694
[TBL] [Abstract] [Full Text] [Related]
12. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract] [Full Text] [Related]
13. Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene
Mae H; Outani H; Imura Y; Chijimatsu R; Inoue A; Kotani Y; Yasuda N; Nakai S; Nakai T; Takenaka S; Okada S
Cancer Res Commun; 2023 Jul; 3(7):1152-1165. PubMed ID: 37405123
[TBL] [Abstract] [Full Text] [Related]
14. Blocking tri-methylguanosine synthase 1 (TGS1) stops anchorage-independent growth of canine sarcomas.
Zucko D; Boris-Lawrie K
Cancer Gene Ther; 2023 Sep; 30(9):1274-1284. PubMed ID: 37386121
[TBL] [Abstract] [Full Text] [Related]
15. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
16. Secondary Peripheral Dedifferentiated Chondrosarcoma: A Case Report with Special Emphasis on the Radiology/Pathology Correlation.
Yoshimoto M; Setsu N; Yokoyama N; Taguchi K; Kohashi K; Oda Y
JBJS Case Connect; 2023 Apr; 13(2):. PubMed ID: 37262190
[TBL] [Abstract] [Full Text] [Related]
17. Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The cap 03 Phase 2 Nonrandomized Clinical Trial.
Mao L; Lian B; Li C; Bai X; Zhou L; Cui C; Chi Z; Sheng X; Wang X; Tang B; Yan X; Li S; Kong Y; Dai J; Wei X; Li J; Duan R; Xu H; Wu X; Yang Y; Cheng F; Zhang C; Xia F; Pang Z; Guo J; Si L
JAMA Oncol; 2023 Aug; 9(8):1099-1107. PubMed ID: 37261804
[TBL] [Abstract] [Full Text] [Related]
18. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract] [Full Text] [Related]
19. Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma.
Shackleford TJ; Hariharan S; Vaseva AV; Alagoa K; Espinoza M; Bid HK; Li F; Zhong H; Phelps DA; Roberts RD; Cam H; London CA; Guttridge DC; Chen Y; Rao M; Shiio Y; Houghton PJ
Mol Cancer Ther; 2023 Apr; 22(4):539-550. PubMed ID: 36696581
[TBL] [Abstract] [Full Text] [Related]
20. Oncolytic strategy using new bifunctional HDACs/brd4 inhibitors against virus-associated lymphomas.
Chen J; Wang Z; Phuc T; Xu Z; Yang D; Chen Z; Lin Z; Kendrick S; Dai L; Li HY; Qin Z
PLoS Pathog; 2023 Jan; 19(1):e1011089. PubMed ID: 36638143
[TBL] [Abstract] [Full Text] [Related]
[Next]